CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(04): 464-470
DOI: 10.4103/JLP.JLP_71_18
Case Report

Catheter associated urinary tract infections due to Trichosporon asahii

Tejashree Anantharaj Urs
Department of Microbiology, Jagadguru Sri Shivarathreeshwara Medical College, Mysore, Karnataka, India
,
Visakha Kadiyala
Department of Microbiology, Jagadguru Sri Shivarathreeshwara Medical College, Mysore, Karnataka, India
,
Saundarya Deepak
Department of Microbiology, Jagadguru Sri Shivarathreeshwara Medical College, Mysore, Karnataka, India
,
Krishna Karthik M.
Department of Microbiology, Jagadguru Sri Shivarathreeshwara Medical College, Mysore, Karnataka, India
› Author Affiliations
Financial support and sponsorship Nil

ABSTRACT

Urinary tract infections (UTIs) caused by fungi, frequently associated with medical devices, have increased and caused great morbidity and mortality among hospitalized patients. Difficulties on different species identification as well as the lack of standardized sensitivity tests in vitro, contribute to the limited information available on epidemiology, diagnosis, and therapeutics of Trichosporon infections. There are only sporadic reports of UTI caused by Trichosporon asahii reported from India. We report six cases of UTI caused by T. asahii in severely ill patients in a tertiary care setup. Among six positive T. asahii UTI, four were found in female patients with a mean age of 60 years. We observed that all patients were on indwelling urinary catheter, broad-spectrum antibiotics, and with other comorbid conditions. With regard to the antifungal susceptibility testing, all the isolates were resistant to amphotericin B and sensitive to voriconazole. Majority of them were sensitive to Itraconazole, half of them were sensitive to fluconazole. The ubiquity and biofilm formation poses difficulty in establishing pathogenicity and delineating environmental or nosocomial infections. Risk factors such as use of antibiotics, indwelling catheter, and comorbidities such as hypertension, diabetes, anemia, and chronic kidney disease predispose for the development of UTI by T. asahii. Isolation of the same yeast in three consecutive urine samples with significant counts, along with significant number of pus cells establishes T. asahii as an etiological agent of UTI. Furthermore, the clearance of the fungus from the urinary tract with the recovery of the patient following catheter removal and antifungal therapy further confirms T. asahii as the cause of UTI.



Publication History

Received: 25 May 2018

Accepted: 23 September 2018

Article published online:
20 February 2020

© 2018.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Botto H. Nosocomial urinary tract infection (NUTI) in adult patients. Med Mal Infect 2003;33:216-7.
  • 2 Ahoyo TA, Bankolé HS, Adéoti FM, Gbohoun AA, Assavèdo S, Amoussou-Guénou M, et al. Prevalence of nosocomial infections and anti-infective therapy in Benin: Results of the first nationwide survey in 2012. Antimicrob Resist Infect Control 2014;3:17.
  • 3 Lucchetti G, Silva AJ, Ueda SM, Perez MC, Mimica LM. Infections of urinary tract: analysis of frequency and sensitivity profile the causative agents of urinary tract infections in patients with chronic bladder catheterization. J Bras Patol Med Lab 2005;41:383-9.
  • 4 Frank DN, Wilson SS, St Amand AL, Pace NR. Culture-independent microbiological analysis of Foley urinary catheter biofilms. PLoS One 2009;4:e7811.
  • 5 Kumar S, Bandyopadhyay M, Mondal S, Pal N. A rare case of nosocomial urinary tract infection due to Trichosporon asahii. J Glob Infect Dis 2011;3:309-10.
  • 6 Júnior AA, Carvalho RT, Focaccia R, Fernandez JG, Araújo HB, Strabelli TM, et al. Emergency of Trichosporon asahii infection in patients with heart failure in unit intensive care unit. Case report and review of literature. Rev Bras Ter Intensiva 2010;20:106-9.
  • 7 Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and trichosporonosis. Clin Microbiol Rev 2011;24:682-700.
  • 8 Sood S, Pathak D, Sharma R, Rishi S. Urinary tract infection by Trichosporon asahii. Indian J Med Microbiol 2006;24:294-6.
  • 9 Chander J. Miscellaneous oppurtunistic mycoses. Textbook of Medical Microbiology. 4th ed., Ch. 28. New Delhi: Jaypee Brothers Medical Publishers Private Limited; 2018. p. 614.
  • 10 Anaissie E. Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review. Clin Infect Dis 1992;14 Suppl 1:S43-53.
  • 11 Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R, Specchia G, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: A retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005;43:1818-28.
  • 12 Lopes HV, Tavares W. Diagnosis of urinary tract infections. Rev Assoc Méd Bras 2005;51:306-8.
  • 13 Mattede Md, Piras C, Mattede KD, Ferrari AT, Baldotto LS, Assbu MS, et al. Urinary tract infections due to Trichosporon spp. in severely ill patients in an Intensive Care Unit. Rev Bras Ter Intensiva 2015;27:247-51.
  • 14 Abelha FJ, Castro MA, Landeiro NM, Neves AM, Santos CC. Mortality and length of stay in a therapy unit intensive surgical. Rev Bras Anestesiol 2006;56:34-45.
  • 15 Khan ID, Sahni AK, Basu A, Haleem S. Trichosporon asahii urinary tract infection in immunocompetent patients. Med J Armed Forces India 2015;71:373-6.
  • 16 Garibaldi RA, Burke JP, Britt MR, Miller MA, Smith CB. Meatal colonization and catheter-associated bacteriuria. N Engl J Med 1980;303:316-8.
  • 17 Platt R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986;124:977-85.
  • 18 Warren J, Bakke A, Desgranchamps F, Johnson JR, Kumon H, Shah J, et al. Catheter-Associated Bacteriuria and the Role of Biomaterial in Prevention. Nosocomial and Health Care Associated Infections in Urology. Plymouth, UK: Health Publications Ltd.; 2001. p. 153-76.
  • 19 Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am 1999;26:821-8.
  • 20 Stamm WE, Hooton TM, Johnson JR, Johnson C, Stapleton A, Roberts PL, et al. Urinary tract infections: From pathogenesis to treatment. J Infect Dis 1989;159:400-6.
  • 21 Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7:342-7.
  • 22 Tenke P, Kovacs B, Bjerklund Johansen TE, Matsumoto T, Tambyah PA, Naber KG, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31 Suppl 1:S68-78.
  • 23 Menezes EA, Carneiro HM, Cunha FA, Oliveira IR, Ângelo MR, Salviano MN. Frequency of microorganisms causing hospital urinary tract infections in general hospital patients from Fortaleza. Rev Bras Anal Clin 2005;37:243-6.
  • 24 Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005;49:4026-34.
  • 25 Walsh TJ, Melcher GP, Rinaldi MG, Lecciones J, McGough DA, Kelly P, et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990;28:1616-22.
  • 26 McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr., Rinaldi MG, et al. in vitro activity of voriconazole against selected fungi. Med Mycol 1998;36:239-42.